Ticker Details
Pulse Biosciences, Inc. Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.
IPO Date:	May 18, 2016
Sector:	Healthcare
Industry:	Medical Instruments and Equipment
Market Cap:	$1.31B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 3.70%
Avg Daily Range (30 D):	$0.73 | 3.56%
Avg Daily Range (90 D):	$0.64 | 3.51%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.2M
Avg Daily Volume (90 D):	.24M

Trade Size
Avg Trade Size (Sh.):	93
Avg Trade Size (Sh.) (30 D):	56
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	139
Avg Institutional Trade:	$1.43M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$.95M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.57M
Avg Closing Trade (30 D):	$.88M
Avg Closing Trade (90 D):	$.89M
Avg Closing Volume:	108.95K

News

Apr 1, 2024 @ 7:33 AM Oxford Industries, PVH And 3 Stocks To Watch Headi... Source: Avi Kapoor

Mar 11, 2024 @ 5:41 PM Why Mesoblast Shares Are Trading Higher By 13%? He... Source: Avi Kapoor

Jan 2, 2024 @ 4:47 PM Rivian Automotive Reports Weak Delivery Figures, J... Source: Avi Kapoor

Dec 19, 2023 @ 6:55 PM Tech Stocks Set New All-Time High, Small Caps On F... Source: Piero Cingari

Dec 13, 2023 @ 12:04 PM $10M Bet On This Healthcare Stock? Check Out These... Source: Avi Kapoor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.08	$-.26	$-1.08
Diluted EPS
Revenue	$.35M	$.26M	$.35M
Gross Profit	$-.19M	$M	$-.19M
Net Income / Loss	$-72.78M	$-17.43M	$-72.78M
Operating Income / Loss	$-76.94M	$-18.25M	$-76.94M
Cost of Revenue	$.54M	$.26M	$.54M
Net Cash Flow	$-37.3M	$-14.48M	$-37.3M
PE Ratio